C4 Therapeutics, Inc. (CCCC)

NMS – Real Time Price. Currency in USD

3.95

+0.08 (2.07%)

Market open: Aug 12, 2026, 11:30 AM EDT

3.86

-0.01 (-0.26%)

Previous after-hours: Aug 11, 2026, 7:58 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

36M

21M

31M

Cost of goods sold

-8M

Gross Profit

28M

13M

24M

Operating expenses (excl. COGS)

-132M

-145M

-152M

-153M

Operating Income

-104M

-117M

-139M

-130M

Non-operating income, total

-384K

12M

Pretax income

-105M

-131M

-128M

Equity in earnings

Taxes

-121K

-131K

-1M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-105M

-132M

-128M

Discontinued operations

Net income

-105M

-132M

-128M

Dilution adjustment

Preferred dividends

C4 Therapeutics, Inc. (CCCC)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

C4 Therapeutics, Inc. (CCCC)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

C4 Therapeutics, Inc. (CCCC)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

C4 Therapeutics, Inc. (CCCC)

Income Statement (Annual)

Income Statement (Annual)